16 reports

Antihypertensive Drugs Market – Scope of the Report This report on the global antihypertensive drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027.The report provides the overall...

  • Antihypertensive
  • World

Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026 The...

  • Antihypertensive
  • In-Store Retail
  • Pharmacy
  • Calcium Channel Blocker
  • World
  • APAC
  • Europe

Abstract: - Global Anti-Hypertensive Drugs Market to Reach $33.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anti-Hypertensive Drugs estimated at US$32.7 Billion in the year 2020, is projected to reach a revised size of US$33.2 Billion by 2027, growing at a CAGR of 0.2% over the analysis period...

  • Antihypertensive
  • World
  • China
  • United States

Anti-hypertensive Drugs Market Report Overview Anti-hypertensive Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Anti-hypertensive Drugs market types and applications. It is a focused study on Anti-hypertensive Drugs market space...

  • Antihypertensive
  • World
  • Health Provider Density

Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd. and Pfizer, Inc. The global anti-hypertensive drugs market is expected to decline from $26.1 billion in 2019 to $23.5 billion in 2020 at a compound annual growth rate (CAGR) of -9.7%. The...

  • Antihypertensive
  • World
  • United States
  • APAC
  • Cause-Specific Mortality Rate

Report Scope: The current report offers a detailed analysis of the antihypertensive drug market.The study includes a discussion of antihypertensive drugs prescribed for lowering the high blood pressure and for the treatment of pulmonary arterial hypertension (PAH). The report excludes drugs used in the treatment...

  • Antihypertensive
  • World
  • Europe
  • North America
  • China
  • Japan
  • Middle East
  • United States
  • APAC
  • Italy
  • United Kingdom
  • Canada
  • Spain
  • France
  • Germany
  • India
  • South America
  • Russia
  • Mexico
  • Africa

KEY FINDINGS During the forecast period from 2019 to 2028, the global antihypertensive drugs market is estimated to grow with a CAGR of 3.21%. A surge in the prevalence of hypertension and a rise in awareness of complications related to hypertension, as well as an increase in the geriatric population and sedentary lifestyle,...

  • Hypertension
  • Antihypertensive
  • World
  • North America

About this market Patients with hypertension are generally treated with drugs that can reduce blood volume (reducing central venous pressure and cardiac output), reduce systemic vascular resistance, and reduce cardiac output by depressing heart rate and stroke volume. For instance, diuretic drugs decrease the blood volume...

  • Hypertension
  • Antihypertensive
  • Generic Drug
  • Diabetes
  • World
  • Diabetes Prevalence

KEY FINDINGS The Asia Pacific antihypertensive drugs market is set to record a significant CAGR of 4.32% during the forecast period, 2019 to 2028. The market growth is attributed to an increase in health care expenses and awareness about the use of antihypertensive drugs. MARKET INSIGHTS The...

  • Antihypertensive
  • Respiratory Disease
  • APAC

KEY FINDINGS The Europe antihypertensive drugs market is estimated to grow with an anticipated CAGR of 2.70% during the forecast years of 2019 to 2028. The region also accounted for harboring the second-largest market share in terms of revenue, in 2019. MARKET INSIGHTS Countries included for...

  • Antihypertensive
  • Europe
  • Germany
  • Italy
  • Mortality Rate

KEY FINDINGS The North America antihypertensive drugs market is predicted to record a CAGR of 3.28% during the forecast period, 2019 to 2028. The growth rate is attributed to factors such as the surge in the predominance of hypertension and persistent kidney disorders. Moreover, prominent players like Johnson & Johnson...

  • Hypertension
  • Antihypertensive
  • North America
  • Canada

This study covers the world outlook for antihypertensive drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Antihypertensive
  • World
  • Gross Domestic Product
  • Disposable Income

Table ##: Anti-hypertensive Therapeutics Market, China, Market Forecast, 2015–2022

  • Therapy
  • Antihypertensive
  • World
  • Smoking Prevalence
  • Elderly Population

Cardiovascular Disorders Drug Development Pipeline Review, 2017 Summary Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia of which accelerate the development of atherosclerotic...

  • Cholesterol
  • Pharmaceutical
  • Heart Failure
  • Hypertension
  • Antihypertensive
  • Statins

The global bioactive ingredient market is expected to reach USD 51.71 billion by 2024, according to a new report by Grand View Research, Inc. Increasing disposable income coupled with growing health awareness among consumers is expected to aid the market growth. Their functional properties are capable of acting on the human metabolism physiology...

  • Medical Benefit
  • Functional Food
  • Coronary Heart Disease
  • Antihypertensive
  • Beverage
  • World
  • China
  • India
  • Disposable Income

Figure ##–##: United States – Forecast for Anti–Hypertensives Off–Label Drugs Market (Billion US$), 2015 – 2020

  • Pharmaceutical
  • Cancer
  • Anti-Infective
  • Neurology
  • Antihypertensive
  • United States
  • Drug Approval
  • Medicine Use